Chhorvann Chhea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chhorvann Chhea has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Heng Sopheab
National Institute of Public Health, Phnom Penh, Cambodia
6 shared publications - Srean Chhim
National Institute of Public Health, Phnom Penh, Cambodia
5 shared publications - Chamnab Ngor
School of Public Health, National Institute of Public Health, Phnom Penh, Cambodia
4 shared publications - Grace Marie Ku
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
4 shared publications - Nawi Ng
School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
3 shared publications - Vichea Ouk
National Center for HIV/AIDS, Dermatology and STD, Phnom Penh, Cambodia
3 shared publications
Latest Publications
- Open Access
Spatial variation and correlates of raised blood pressure in Cambodia: a Gaussian-process geostatistical analysis of the 2023 STEPwise survey
Introduction: Raised blood pressure is an important cardiovascular risk factor in Cambodia; however, national averages may obscure substantial local geographic heterogeneity. We assessed the spatial distribution of raised blood pressure and its demographic, metabolic, behavioural, built-environment, and environmental correlates using the 2023 Cambodia STEPwise approach to noncommunicable disease (NCD) risk factor surveillance (STEPS) survey. Methods: We analysed 289 georeferenced primary sampling units (PSUs) from the 2023 Cambodia STEPS Survey. PSU-level case counts and numbers of adults with valid blood pressure data were modelled using a frequentist binomial generalised additive model with a two-dimensional Gaussian-process smooth. An explanatory model included selected PSU-level and contextual covariates; a separate mapping model used spatially continuous predictors to generate predictions on a 5-km grid. Design-based national and residence-specific prevalence estimates were calculated separately using the survey design and Step-2 weights. Results: Among 4,225 adults with valid blood pressure data, unweighted prevalence of raised blood pressure was 28.6%, compared with 18.8% after Step-2 weighting; weighted prevalence was 17.5% in rural areas and 21.7% in urban/suburban areas. Mean observed unweighted PSU-level prevalence was 29.0%. In the adjusted spatial explanatory model, the proportion aged 60–69 years (β=1.969, SE=0.327; p<0.001) and overweight/obesity prevalence (β=0.996, SE=0.265; p<0.001) were positive ecological correlates. The spatial model had lower Akaike information criterion and residual deviance than its non-spatial counterpart, although Bayesian information criterion was higher. Prediction uncertainty was greater in some sparsely sampled areas. Conclusions: Raised blood pressure showed significant geographic heterogeneity across Cambodia. Older age composition and overweight/obesity prevalence were positive PSU-level correlates, not individual-level causal effects. Predicted prevalence should be interpreted alongside uncertainty and should complement, rather than replace, design-based STEPS prevalence estimates for geographically informed NCD planning. WHAT IS ALREADY KNOWN ON THIS TOPIC: Cambodia’s national STEPS Survey indicates a rising burden of raised blood pressure, but national averages cannot show fine-scale geographic heterogeneity or identify areas where model-based spatial estimates are least precise. WHAT THIS STUDY ADDS: Using 289 georeferenced PSUs, this study distinguishes survey-weighted prevalence estimation from unweighted PSU-level geostatistical modelling, identifies older age composition and overweight/obesity as the strongest adjusted ecological correlates, and maps predicted prevalence alongside prediction standard errors and 95% confidence limits. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY: The maps can complement STEPS and routine NCD indicators by identifying geographic variations in the modelled raised blood pressure burden while explicitly identifying where the uncertainty is high. Areas with elevated predicted raised blood pressure prevalence and acceptable precision may warrant closer assessment of screening and treatment capacity, whereas areas with high uncertainty may benefit from additional surveillance.
Open AccessSpatial variation and correlates of raised blood pressure in Cambodia: a Gaussian-process geostatistical analysis of the 2023 STEPwise survey
Introduction: Raised blood pressure is an important cardiovascular risk factor in Cambodia; however, national averages may obscure substantial local geographic heterogeneity. We assessed the spatial distribution of raised blood pressure and its demographic, metabolic, behavioural, built-environment, and environmental correlates using the 2023 Cambodia STEPwise approach to noncommunicable disease (NCD) risk factor surveillance (STEPS) survey. Methods: We analysed 289 georeferenced primary sampling units (PSUs) from the 2023 Cambodia STEPS Survey. PSU-level case counts and numbers of adults with valid blood pressure data were modelled using a frequentist binomial generalised additive model with a two-dimensional Gaussian-process smooth. An explanatory model included selected PSU-level and contextual covariates; a separate mapping model used spatially continuous predictors to generate predictions on a 5-km grid. Design-based national and residence-specific prevalence estimates were calculated separately using the survey design and Step-2 weights. Results: Among 4,225 adults with valid blood pressure data, unweighted prevalence of raised blood pressure was 28.6%, compared with 18.8% after Step-2 weighting; weighted prevalence was 17.5% in rural areas and 21.7% in urban/suburban areas. Mean observed unweighted PSU-level prevalence was 29.0%. In the adjusted spatial explanatory model, the proportion aged 60–69 years (β=1.969, SE=0.327; p<0.001) and overweight/obesity prevalence (β=0.996, SE=0.265; p<0.001) were positive ecological correlates. The spatial model had lower Akaike information criterion and residual deviance than its non-spatial counterpart, although Bayesian information criterion was higher. Prediction uncertainty was greater in some sparsely sampled areas. Conclusions: Raised blood pressure showed significant geographic heterogeneity across Cambodia. Older age composition and overweight/obesity prevalence were positive PSU-level correlates, not individual-level causal effects. Predicted prevalence should be interpreted alongside uncertainty and should complement, rather than replace, design-based STEPS prevalence estimates for geographically informed NCD planning. WHAT IS ALREADY KNOWN ON THIS TOPIC: Cambodia’s national STEPS Survey indicates a rising burden of raised blood pressure, but national averages cannot show fine-scale geographic heterogeneity or identify areas where model-based spatial estimates are least precise. WHAT THIS STUDY ADDS: Using 289 georeferenced PSUs, this study distinguishes survey-weighted prevalence estimation from unweighted PSU-level geostatistical modelling, identifies older age composition and overweight/obesity as the strongest adjusted ecological correlates, and maps predicted prevalence alongside prediction standard errors and 95% confidence limits. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY: The maps can complement STEPS and routine NCD indicators by identifying geographic variations in the modelled raised blood pressure burden while explicitly identifying where the uncertainty is high. Areas with elevated predicted raised blood pressure prevalence and acceptable precision may warrant closer assessment of screening and treatment capacity, whereas areas with high uncertainty may benefit from additional surveillance.
- 27 February 2026
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 38 (2-3) , 212-219
Sociodemographic Factors Associated With the Diet Quality of Schoolchildren in Rural Cambodia
This cross-sectional study examined sociodemographic factors influencing diet quality among 691 Cambodian schoolchildren aged 6 to 11 years. The average Global Dietary Recommendation (GDR) score was 9.47, with 49% achieving a GDR-healthy diet. Only 15.63% consumed All-5 recommended food groups, whereas 63.53% met the minimum dietary diversity (MDD). After adjusting for confounding factors, children aged 9 to 11 years were significantly more likely to consume all five food groups than those aged 6 to 8 years (adjusted odds ratio [AOR] = 1.55, 95% confidence interval, CI [1.02, 2.37], P = .04). Schoolchildren with caregivers having only primary education were significantly less likely to meet the MDD (AOR = 0.49, 95% CI [0.27, 0.90], P = .02). Interventions should prioritize improving diet quality among school-aged children by fostering multisectoral collaboration to create healthier school food environments and ensure access to diverse, nutritious foods.
- 27 February 2026
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 38 (2-3) , 212-219
Sociodemographic Factors Associated With the Diet Quality of Schoolchildren in Rural Cambodia
This cross-sectional study examined sociodemographic factors influencing diet quality among 691 Cambodian schoolchildren aged 6 to 11 years. The average Global Dietary Recommendation (GDR) score was 9.47, with 49% achieving a GDR-healthy diet. Only 15.63% consumed All-5 recommended food groups, whereas 63.53% met the minimum dietary diversity (MDD). After adjusting for confounding factors, children aged 9 to 11 years were significantly more likely to consume all five food groups than those aged 6 to 8 years (adjusted odds ratio [AOR] = 1.55, 95% confidence interval, CI [1.02, 2.37], P = .04). Schoolchildren with caregivers having only primary education were significantly less likely to meet the MDD (AOR = 0.49, 95% CI [0.27, 0.90], P = .02). Interventions should prioritize improving diet quality among school-aged children by fostering multisectoral collaboration to create healthier school food environments and ensure access to diverse, nutritious foods.
- Open Access
Prevalence and factors associated with pre-diabetes and undiagnosed diabetes in Cambodia: cross-sectional study based on the World Health Survey Plus 2023
Objective: This study aimed to determine the prevalence and factors associated with pre-diabetes and undiagnosed type 2 diabetes (UDD) in Cambodia. Design: This analysis used data from the WHO World Health Survey Plus, which was collected using a cross-sectional design with a GIS-based, three-stage sampling approach. Multiple logistic regression was used to identify key associated factors, based on a significance level of p<0.05. Setting: Data were collected from all 25 provinces in Cambodia between 12 March 2023 and 31 May 2023. Participants: 4427 individuals aged 18 years or older, residing in the selected household for at least 6 months in the past year. Primary outcome measures: Pre-diabetes (Haemoglobin A1c (HbA1c) 5.7%–6.4%) and UDD (HbA1c≥6.5%), without prior knowledge of having type 2 diabetes (T2D). Results: The weighted prevalences of pre-diabetes and UDD were 26.4% (95% CI 24.0% to 29.0%) and 9.3% (95% CI 7.9% to 11.0%). Pre-diabetes prevalence was higher in urban areas compared with rural areas (adjusted OR, aOR=1.2, 95% CI 1.0 to 1.4), males (aOR=1.7, 95% CI 1.3 to 2.3), individuals aged 40–49 (aOR=1.8, 95% CI 1.4 to 2.4), individuals aged 50+ years group (aOR=2.9, 95% CI 2.3 to 3.6) compared with the 18–39 years group, overweight individuals (aOR=1.7, 95% CI 1.4 to 2.0), obese (aOR=2.1, 95% CI 1.5 to 3.0) and those with elevated total triglycerides (aOR=1.3, 95% CI 1.1 to 1.5). Similar risk factors were identified for UDD, with the addition of hypertension (aOR=1.6, 95% CI 1.3 to 2.0) and high waist circumference (aOR=2.0, 95% CI 1.5 to 2.7). Conclusions: The high prevalence of pre-diabetes and UDD in Cambodia is a pressing public health concern. Urgent and intensive interventions are needed to effectively prevent and manage T2D, particularly among urban residents, older persons and individuals with metabolic risk factors.
Open AccessPrevalence and factors associated with pre-diabetes and undiagnosed diabetes in Cambodia: cross-sectional study based on the World Health Survey Plus 2023
Objective: This study aimed to determine the prevalence and factors associated with pre-diabetes and undiagnosed type 2 diabetes (UDD) in Cambodia. Design: This analysis used data from the WHO World Health Survey Plus, which was collected using a cross-sectional design with a GIS-based, three-stage sampling approach. Multiple logistic regression was used to identify key associated factors, based on a significance level of p<0.05. Setting: Data were collected from all 25 provinces in Cambodia between 12 March 2023 and 31 May 2023. Participants: 4427 individuals aged 18 years or older, residing in the selected household for at least 6 months in the past year. Primary outcome measures: Pre-diabetes (Haemoglobin A1c (HbA1c) 5.7%–6.4%) and UDD (HbA1c≥6.5%), without prior knowledge of having type 2 diabetes (T2D). Results: The weighted prevalences of pre-diabetes and UDD were 26.4% (95% CI 24.0% to 29.0%) and 9.3% (95% CI 7.9% to 11.0%). Pre-diabetes prevalence was higher in urban areas compared with rural areas (adjusted OR, aOR=1.2, 95% CI 1.0 to 1.4), males (aOR=1.7, 95% CI 1.3 to 2.3), individuals aged 40–49 (aOR=1.8, 95% CI 1.4 to 2.4), individuals aged 50+ years group (aOR=2.9, 95% CI 2.3 to 3.6) compared with the 18–39 years group, overweight individuals (aOR=1.7, 95% CI 1.4 to 2.0), obese (aOR=2.1, 95% CI 1.5 to 3.0) and those with elevated total triglycerides (aOR=1.3, 95% CI 1.1 to 1.5). Similar risk factors were identified for UDD, with the addition of hypertension (aOR=1.6, 95% CI 1.3 to 2.0) and high waist circumference (aOR=2.0, 95% CI 1.5 to 2.7). Conclusions: The high prevalence of pre-diabetes and UDD in Cambodia is a pressing public health concern. Urgent and intensive interventions are needed to effectively prevent and manage T2D, particularly among urban residents, older persons and individuals with metabolic risk factors.
- Open Access
Barriers and enablers to healthcare access for older adults in Cambodia: perspectives of healthcare professionals – a qualitative study
Objective To explore health professionals’ perspectives on the barriers and enablers of healthcare access for older adults in Cambodia. Design A qualitative study based on semi-structured interviews conducted in Khmer, recorded, transcribed, translated into English and analysed using an abductive thematic analysis approach. Setting Phnom Penh, Cambodia. Participants A purposive sample of 11 health professionals serving in diverse roles and sectors participated in the study. Results Three key barriers emerged: (1) institutional barriers, (2) patient-specific access barriers and (3) communication barriers. However, four key enablers were also identified: (1) supportive healthcare environment, (2) reaching out to improve access to health services, (3) peer and community engagement and (4) government direct support to access healthcare. Despite previous policy efforts, gaps in the implementation of healthcare services for older adults persist across all health facilities. Health professionals identified that improving healthcare access for older adults in Cambodia requires a multifaceted strategy involving proactive outreach, health promotion, financial assistance and stronger community and family support. Conclusion Effective policy implementation requires collaboration among stakeholders and the active involvement of older adults in programme design to enhance dignity and well-being in Cambodia’s ageing population.
Open AccessBarriers and enablers to healthcare access for older adults in Cambodia: perspectives of healthcare professionals – a qualitative study
Objective To explore health professionals’ perspectives on the barriers and enablers of healthcare access for older adults in Cambodia. Design A qualitative study based on semi-structured interviews conducted in Khmer, recorded, transcribed, translated into English and analysed using an abductive thematic analysis approach. Setting Phnom Penh, Cambodia. Participants A purposive sample of 11 health professionals serving in diverse roles and sectors participated in the study. Results Three key barriers emerged: (1) institutional barriers, (2) patient-specific access barriers and (3) communication barriers. However, four key enablers were also identified: (1) supportive healthcare environment, (2) reaching out to improve access to health services, (3) peer and community engagement and (4) government direct support to access healthcare. Despite previous policy efforts, gaps in the implementation of healthcare services for older adults persist across all health facilities. Health professionals identified that improving healthcare access for older adults in Cambodia requires a multifaceted strategy involving proactive outreach, health promotion, financial assistance and stronger community and family support. Conclusion Effective policy implementation requires collaboration among stakeholders and the active involvement of older adults in programme design to enhance dignity and well-being in Cambodia’s ageing population.
- Open Access
Prevalence and factors associated with prediabetes and undiagnosed diabetes in Cambodia: Cross-sectional study based on the World Health Survey Plus 2023
Background: This study aimed to determine the prevalence and factors associated with pre-type 2 diabetes (pre-T2D) and undiagnosed T2D (UDD) in Cambodia. Methods: This cross-sectional study included 5,271 individuals aged ≥ 18 years from all provinces in Cambodia. Pre-T2D and UDD were defined using the World Health Organization (WHO)’s haemoglobin A1c criteria. Results: The weighted prevalences of pre-T2D and UDD were 27.2% and 10.9%. Pre-T2D prevalence was higher in urban areas compared to rural areas (aOR = 1.2, 95% CI: 1.0 - 1.4), females aged 30-39 (aOR=1.4, 95% CI: 1.0 - 2.0), females 40-49 (aOR=2.4, 95% CI: 1.7 - 3.3), females 50+ (aOR = 3.8, 95% CI: 2.8 - 5.1), and males aged 30-39 (aOR=2.0, 95% CI: 1.3 - 3.0), males 40-49 (aOR=2.3, 95% CI: 1.5 - 3.3), males 50+ (aOR = 3.3, 95% CI: 2.4 - 4.7) relative to females aged 18-29, overweight individuals (aOR = 1.6, 95% CI: 1.3 - 1.9), obese individuals (aOR = 1.9, 95% CI: 1.5 - 2.4), those with high waist circumference (aOR = 1.5, 95% CI: 1.2 - 1.8), and elevated total triglycerides (aOR = 1.3, 95% CI: 1.1 - 1.5). Similar risk factors were identified for UDD, with the addition of elevated blood pressure (aOR = 1.5, 95% CI: 1.1 - 2.1). Conclusion: The high prevalence of pre-T2D and UDD in Cambodia is a pressing public health concern. Urgent and intensive interventions are needed to effectively prevent and manage T2D, particularly among urban residents, older adults, and individuals with metabolic risk factors. Key messages: What is already known on this topic: In 2023, the national prevalence of pre-type 2 diabetes (pre-T2D), measured by impaired fasting glycaemia, among adults (18+) in Cambodia was estimated to be 5.5%, with a higher prevalence in older adults and females. The prevalence of undiagnosed T2D (UDD) was not estimated. What this study adds: This study revealed a significant prevalence of pre-T2D (27.2%) and UDD (10.9%) among adults (18+ years old) in Cambodia, indicating a substantial public health challenge that requires immediate attention. This study identified modifiable and non-modifiable factors associated with pre-T2D and UDD, including urban residence, older age, overweight or obese, high waist circumference, elevated triglyceride levels, and elevated blood pressure. How this study might affect research, practice, or policy: These findings underscore the importance of prevention and screening initiatives aimed at early detection to mitigate T2D and to delay or prevent complications in individuals with UDD.
Open AccessPrevalence and factors associated with prediabetes and undiagnosed diabetes in Cambodia: Cross-sectional study based on the World Health Survey Plus 2023
Background: This study aimed to determine the prevalence and factors associated with pre-type 2 diabetes (pre-T2D) and undiagnosed T2D (UDD) in Cambodia. Methods: This cross-sectional study included 5,271 individuals aged ≥ 18 years from all provinces in Cambodia. Pre-T2D and UDD were defined using the World Health Organization (WHO)’s haemoglobin A1c criteria. Results: The weighted prevalences of pre-T2D and UDD were 27.2% and 10.9%. Pre-T2D prevalence was higher in urban areas compared to rural areas (aOR = 1.2, 95% CI: 1.0 - 1.4), females aged 30-39 (aOR=1.4, 95% CI: 1.0 - 2.0), females 40-49 (aOR=2.4, 95% CI: 1.7 - 3.3), females 50+ (aOR = 3.8, 95% CI: 2.8 - 5.1), and males aged 30-39 (aOR=2.0, 95% CI: 1.3 - 3.0), males 40-49 (aOR=2.3, 95% CI: 1.5 - 3.3), males 50+ (aOR = 3.3, 95% CI: 2.4 - 4.7) relative to females aged 18-29, overweight individuals (aOR = 1.6, 95% CI: 1.3 - 1.9), obese individuals (aOR = 1.9, 95% CI: 1.5 - 2.4), those with high waist circumference (aOR = 1.5, 95% CI: 1.2 - 1.8), and elevated total triglycerides (aOR = 1.3, 95% CI: 1.1 - 1.5). Similar risk factors were identified for UDD, with the addition of elevated blood pressure (aOR = 1.5, 95% CI: 1.1 - 2.1). Conclusion: The high prevalence of pre-T2D and UDD in Cambodia is a pressing public health concern. Urgent and intensive interventions are needed to effectively prevent and manage T2D, particularly among urban residents, older adults, and individuals with metabolic risk factors. Key messages: What is already known on this topic: In 2023, the national prevalence of pre-type 2 diabetes (pre-T2D), measured by impaired fasting glycaemia, among adults (18+) in Cambodia was estimated to be 5.5%, with a higher prevalence in older adults and females. The prevalence of undiagnosed T2D (UDD) was not estimated. What this study adds: This study revealed a significant prevalence of pre-T2D (27.2%) and UDD (10.9%) among adults (18+ years old) in Cambodia, indicating a substantial public health challenge that requires immediate attention. This study identified modifiable and non-modifiable factors associated with pre-T2D and UDD, including urban residence, older age, overweight or obese, high waist circumference, elevated triglyceride levels, and elevated blood pressure. How this study might affect research, practice, or policy: These findings underscore the importance of prevention and screening initiatives aimed at early detection to mitigate T2D and to delay or prevent complications in individuals with UDD.
- Open Access
- 29 June 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e48923
Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People With HIV (Project EndIT): Protocol for a Randomized Controlled Trial
Background: The prevalence of smoking remains high in many low- and middle-income countries (LMICs), including the Southeast Asian nation of Cambodia. Smoking is especially hazardous for people with HIV. In Cambodia, approximately 43%-65% of men with HIV and 3%-5% of women with HIV smoke cigarettes. Thus, there is a critical need for cost-effective smoking cessation interventions for Cambodian people with HIV. This paper describes the design, methods, and data analysis plans for a randomized controlled trial assessing the efficacy of a theory-based mobile health smoking cessation intervention in Cambodian people with HIV. Objective: This 2-group randomized controlled trial compares the efficacy of a mobile health–based automated messaging (AM) intervention versus standard care (SC) in facilitating smoking cessation among Cambodian people with HIV. Methods: Cambodian people with HIV who currently smoke and are receiving antiretroviral treatment (target, N=800) will be randomized to (1) SC or (2) the AM intervention. SC participants will receive brief advice to quit smoking, written self-help materials, nicotine patches, and will complete weekly app-delivered dietary assessments for 26 weeks. AM participants will receive all SC components (but will complete smoking-related weekly assessments instead of dietary assessments), in addition to a fully automated tailored messaging program driven by the weekly assessments to facilitate smoking cessation. In the Phase-Based Model of smoking cessation, the cessation process is partitioned into 4 phases: motivation, preparation (precessation), cessation (quit date to 2 weeks post quit), and maintenance (up to 6 months post quit). Our AM program targets processes within these phases, including increasing motivation to quit, enhancing self-efficacy, obtaining social support, skills to cope with nicotine withdrawal symptoms and stress, and skills to maintain abstinence. All participants will complete baseline and 3-, 6-, and 12-month in-person follow-up assessments. The primary outcome is biochemically confirmed abstinence at 12 months, with 3- and 6-month abstinence as secondary outcomes. Potential mediators and moderators underlying treatment effects will be explored, and cost-effectiveness will be assessed. Results: This study was approved by all relevant domestic and international institutional and ethical review boards. Participant recruitment commenced in January 2023. Data collection is expected to conclude by the end of 2025. Conclusions: By demonstrating the greater efficacy and cost-effectiveness of AM relative to SC, this study has the potential to transform HIV care in Cambodia and prevent tobacco-related diseases. Furthermore, it may be adapted for use in other Cambodian populations and in other low- and middle-income countries. Ultimately, the AM approach to smoking cessation could greatly improve public health in the developing world and beyond. Trial Registration: ClinicalTrials.gov NCT05746442; https://clinicaltrials.gov/ct2/show/NCT05746442 International Registered Report Identifier (IRRID): PRR1-10.2196/48923
- 29 June 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e48923
Open AccessEnding Tobacco Use Through Interactive Tailored Messaging for Cambodian People With HIV (Project EndIT): Protocol for a Randomized Controlled Trial
Background: The prevalence of smoking remains high in many low- and middle-income countries (LMICs), including the Southeast Asian nation of Cambodia. Smoking is especially hazardous for people with HIV. In Cambodia, approximately 43%-65% of men with HIV and 3%-5% of women with HIV smoke cigarettes. Thus, there is a critical need for cost-effective smoking cessation interventions for Cambodian people with HIV. This paper describes the design, methods, and data analysis plans for a randomized controlled trial assessing the efficacy of a theory-based mobile health smoking cessation intervention in Cambodian people with HIV. Objective: This 2-group randomized controlled trial compares the efficacy of a mobile health–based automated messaging (AM) intervention versus standard care (SC) in facilitating smoking cessation among Cambodian people with HIV. Methods: Cambodian people with HIV who currently smoke and are receiving antiretroviral treatment (target, N=800) will be randomized to (1) SC or (2) the AM intervention. SC participants will receive brief advice to quit smoking, written self-help materials, nicotine patches, and will complete weekly app-delivered dietary assessments for 26 weeks. AM participants will receive all SC components (but will complete smoking-related weekly assessments instead of dietary assessments), in addition to a fully automated tailored messaging program driven by the weekly assessments to facilitate smoking cessation. In the Phase-Based Model of smoking cessation, the cessation process is partitioned into 4 phases: motivation, preparation (precessation), cessation (quit date to 2 weeks post quit), and maintenance (up to 6 months post quit). Our AM program targets processes within these phases, including increasing motivation to quit, enhancing self-efficacy, obtaining social support, skills to cope with nicotine withdrawal symptoms and stress, and skills to maintain abstinence. All participants will complete baseline and 3-, 6-, and 12-month in-person follow-up assessments. The primary outcome is biochemically confirmed abstinence at 12 months, with 3- and 6-month abstinence as secondary outcomes. Potential mediators and moderators underlying treatment effects will be explored, and cost-effectiveness will be assessed. Results: This study was approved by all relevant domestic and international institutional and ethical review boards. Participant recruitment commenced in January 2023. Data collection is expected to conclude by the end of 2025. Conclusions: By demonstrating the greater efficacy and cost-effectiveness of AM relative to SC, this study has the potential to transform HIV care in Cambodia and prevent tobacco-related diseases. Furthermore, it may be adapted for use in other Cambodian populations and in other low- and middle-income countries. Ultimately, the AM approach to smoking cessation could greatly improve public health in the developing world and beyond. Trial Registration: ClinicalTrials.gov NCT05746442; https://clinicaltrials.gov/ct2/show/NCT05746442 International Registered Report Identifier (IRRID): PRR1-10.2196/48923
- Open Access
- 11 May 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People With HIV (Project EndIT): Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND The prevalence of smoking remains high in many low- and middle-income countries (LMICs), including the Southeast Asian nation of Cambodia. Smoking is especially hazardous for people with HIV. In Cambodia, approximately 43%-65% of men with HIV and 3%-5% of women with HIV smoke cigarettes. Thus, there is a critical need for cost-effective smoking cessation interventions for Cambodian people with HIV. This paper describes the design, methods, and data analysis plans for a randomized controlled trial assessing the efficacy of a theory-based mobile health smoking cessation intervention in Cambodian people with HIV. OBJECTIVE This 2-group randomized controlled trial compares the efficacy of a mobile health–based automated messaging (AM) intervention versus standard care (SC) in facilitating smoking cessation among Cambodian people with HIV. METHODS Cambodian people with HIV who currently smoke and are receiving antiretroviral treatment (target, N=800) will be randomized to (1) SC or (2) the AM intervention. SC participants will receive brief advice to quit smoking, written self-help materials, nicotine patches, and will complete weekly app-delivered dietary assessments for 26 weeks. AM participants will receive all SC components (but will complete smoking-related weekly assessments instead of dietary assessments), in addition to a fully automated tailored messaging program driven by the weekly assessments to facilitate smoking cessation. In the Phase-Based Model of smoking cessation, the cessation process is partitioned into 4 phases: motivation, preparation (precessation), cessation (quit date to 2 weeks post quit), and maintenance (up to 6 months post quit). Our AM program targets processes within these phases, including increasing motivation to quit, enhancing self-efficacy, obtaining social support, skills to cope with nicotine withdrawal symptoms and stress, and skills to maintain abstinence. All participants will complete baseline and 3-, 6-, and 12-month in-person follow-up assessments. The primary outcome is biochemically confirmed abstinence at 12 months, with 3- and 6-month abstinence as secondary outcomes. Potential mediators and moderators underlying treatment effects will be explored, and cost-effectiveness will be assessed. RESULTS This study was approved by all relevant domestic and international institutional and ethical review boards. Participant recruitment commenced in January 2023. Data collection is expected to conclude by the end of 2025. CONCLUSIONS By demonstrating the greater efficacy and cost-effectiveness of AM relative to SC, this study has the potential to transform HIV care in Cambodia and prevent tobacco-related diseases. Furthermore, it may be adapted for use in other Cambodian populations and in other low- and middle-income countries. Ultimately, the AM approach to smoking cessation could greatly improve public health in the developing world and beyond. CLINICALTRIAL ClinicalTrials.gov NCT05746442; https://clinicaltrials.gov/ct2/show/NCT05746442 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/48923
- 11 May 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEnding Tobacco Use Through Interactive Tailored Messaging for Cambodian People With HIV (Project EndIT): Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND The prevalence of smoking remains high in many low- and middle-income countries (LMICs), including the Southeast Asian nation of Cambodia. Smoking is especially hazardous for people with HIV. In Cambodia, approximately 43%-65% of men with HIV and 3%-5% of women with HIV smoke cigarettes. Thus, there is a critical need for cost-effective smoking cessation interventions for Cambodian people with HIV. This paper describes the design, methods, and data analysis plans for a randomized controlled trial assessing the efficacy of a theory-based mobile health smoking cessation intervention in Cambodian people with HIV. OBJECTIVE This 2-group randomized controlled trial compares the efficacy of a mobile health–based automated messaging (AM) intervention versus standard care (SC) in facilitating smoking cessation among Cambodian people with HIV. METHODS Cambodian people with HIV who currently smoke and are receiving antiretroviral treatment (target, N=800) will be randomized to (1) SC or (2) the AM intervention. SC participants will receive brief advice to quit smoking, written self-help materials, nicotine patches, and will complete weekly app-delivered dietary assessments for 26 weeks. AM participants will receive all SC components (but will complete smoking-related weekly assessments instead of dietary assessments), in addition to a fully automated tailored messaging program driven by the weekly assessments to facilitate smoking cessation. In the Phase-Based Model of smoking cessation, the cessation process is partitioned into 4 phases: motivation, preparation (precessation), cessation (quit date to 2 weeks post quit), and maintenance (up to 6 months post quit). Our AM program targets processes within these phases, including increasing motivation to quit, enhancing self-efficacy, obtaining social support, skills to cope with nicotine withdrawal symptoms and stress, and skills to maintain abstinence. All participants will complete baseline and 3-, 6-, and 12-month in-person follow-up assessments. The primary outcome is biochemically confirmed abstinence at 12 months, with 3- and 6-month abstinence as secondary outcomes. Potential mediators and moderators underlying treatment effects will be explored, and cost-effectiveness will be assessed. RESULTS This study was approved by all relevant domestic and international institutional and ethical review boards. Participant recruitment commenced in January 2023. Data collection is expected to conclude by the end of 2025. CONCLUSIONS By demonstrating the greater efficacy and cost-effectiveness of AM relative to SC, this study has the potential to transform HIV care in Cambodia and prevent tobacco-related diseases. Furthermore, it may be adapted for use in other Cambodian populations and in other low- and middle-income countries. Ultimately, the AM approach to smoking cessation could greatly improve public health in the developing world and beyond. CLINICALTRIAL ClinicalTrials.gov NCT05746442; https://clinicaltrials.gov/ct2/show/NCT05746442 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/48923
- Open Access
- 3 May 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (5) , e011885
Descriptive assessment of COVID-19 responses and lessons learnt in Cambodia, January 2020 to June 2022
As a member state of the International Health Regulations 2005, Cambodia is continuously strengthening its capacity to respond to health emergencies and prevent the international spread of diseases. Despite this, Cambodia’s capacity to prevent, detect and rapidly respond to public health threats remained limited at the onset of the pandemic, as was the case in most countries. This paper describes epidemiological phases, response phases, strategy and lessons learnt in Cambodia between 27 January 2020 and 30 June 2022. We classified epidemiological phases in Cambodia into three phases, in which Cambodia responded using eight measures: (1) detect, isolate/quarantine; (2) face coverings, hand hygiene and physical distancing measures; (3) risk communication and community engagement; (4) school closures; (5) border closures; (6) public event and gathering cancellation; (7) vaccination; and (8) lockdown. The measures corresponded to six strategies: (1) setting up and managing a new response system, (2) containing the spread with early response, (3) strengthening the identification of cases and contacts, (4) strengthening care for patients with COVID-19, (5) boosting vaccination coverage and (6) supporting disadvantaged groups. Thirteen lessons were learnt for future health emergency responses. Findings suggest that Cambodia successfully contained the spread of SARS-CoV-2 in the first year and quickly attained high vaccine coverage by the second year of the response. The core of this success was the strong political will and high level of cooperation from the public. However, Cambodia needs to further improve its infrastructure for quarantining and isolating cases and close contacts and laboratory capacity for future health emergencies.
- 3 May 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (5) , e011885
Open AccessDescriptive assessment of COVID-19 responses and lessons learnt in Cambodia, January 2020 to June 2022
As a member state of the International Health Regulations 2005, Cambodia is continuously strengthening its capacity to respond to health emergencies and prevent the international spread of diseases. Despite this, Cambodia’s capacity to prevent, detect and rapidly respond to public health threats remained limited at the onset of the pandemic, as was the case in most countries. This paper describes epidemiological phases, response phases, strategy and lessons learnt in Cambodia between 27 January 2020 and 30 June 2022. We classified epidemiological phases in Cambodia into three phases, in which Cambodia responded using eight measures: (1) detect, isolate/quarantine; (2) face coverings, hand hygiene and physical distancing measures; (3) risk communication and community engagement; (4) school closures; (5) border closures; (6) public event and gathering cancellation; (7) vaccination; and (8) lockdown. The measures corresponded to six strategies: (1) setting up and managing a new response system, (2) containing the spread with early response, (3) strengthening the identification of cases and contacts, (4) strengthening care for patients with COVID-19, (5) boosting vaccination coverage and (6) supporting disadvantaged groups. Thirteen lessons were learnt for future health emergency responses. Findings suggest that Cambodia successfully contained the spread of SARS-CoV-2 in the first year and quickly attained high vaccine coverage by the second year of the response. The core of this success was the strong political will and high level of cooperation from the public. However, Cambodia needs to further improve its infrastructure for quarantining and isolating cases and close contacts and laboratory capacity for future health emergencies.
- Open Access
- 18 January 2023
- Published by World Health Organization, Western Pacific Regional Office in Western Pacific Surveillance and Response Journal
- Vol. 14 (1) , 60-66
A descriptive assessment of the National Institute of Public Health’s role in supporting the COVID-19 response in Cambodia, 2020–2021
Objective: This paper examines the contributions made by the National Institute of Public Health to Cambodia’s response to the coronavirus disease (COVID-19) pandemic during 2020–2021. Methods: The activities conducted by the Institute were compared with adaptations of the nine pillars of the World Health Organization’s 2020 COVID-19 strategic preparedness and response plan. To gather relevant evidence, we reviewed national COVID-19 testing data, information about COVID-19-related events documented by Institute staff, and financial and technical reports of the Institute’s activities. Results: The main contributions the Institute made were to the laboratory pillar and the incident management and planning pillar. The Institute tested more than 50% of the 2 575 391 samples for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and provided technical advice about establishing 18 new laboratories for SARS-CoV-2 testing in the capital city of Phnom Penh and 11 provinces. The Institute had representatives on many national committees and coauthored national guidelines for implementing rapid COVID-19 testing, preventing transmission in health-care facilities and providing treatment. The Institute contributed to six other pillars, but had no active role in risk communication and community engagement. Discussion: The Institute’s support was essential to the COVID-19 response in Cambodia, especially for laboratory services and incident management and planning. Based on the contributions made by the Institute during the COVID-19 pandemic, continued investment in it will be critical to allow it to support responses to future health emergencies in Cambodia.
- 18 January 2023
- Published by World Health Organization, Western Pacific Regional Office in Western Pacific Surveillance and Response Journal
- Vol. 14 (1) , 60-66
Open AccessA descriptive assessment of the National Institute of Public Health’s role in supporting the COVID-19 response in Cambodia, 2020–2021
Objective: This paper examines the contributions made by the National Institute of Public Health to Cambodia’s response to the coronavirus disease (COVID-19) pandemic during 2020–2021. Methods: The activities conducted by the Institute were compared with adaptations of the nine pillars of the World Health Organization’s 2020 COVID-19 strategic preparedness and response plan. To gather relevant evidence, we reviewed national COVID-19 testing data, information about COVID-19-related events documented by Institute staff, and financial and technical reports of the Institute’s activities. Results: The main contributions the Institute made were to the laboratory pillar and the incident management and planning pillar. The Institute tested more than 50% of the 2 575 391 samples for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and provided technical advice about establishing 18 new laboratories for SARS-CoV-2 testing in the capital city of Phnom Penh and 11 provinces. The Institute had representatives on many national committees and coauthored national guidelines for implementing rapid COVID-19 testing, preventing transmission in health-care facilities and providing treatment. The Institute contributed to six other pillars, but had no active role in risk communication and community engagement. Discussion: The Institute’s support was essential to the COVID-19 response in Cambodia, especially for laboratory services and incident management and planning. Based on the contributions made by the Institute during the COVID-19 pandemic, continued investment in it will be critical to allow it to support responses to future health emergencies in Cambodia.
- Open Access
- 5 January 2023
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 38 (3) , 342-350
Benefits and challenges of consolidating public health functions into a National Public Health Institute: a policy analysis
National Public Health Institutes (NPHIs) around the world vary in composition. Consolidated organizational models can bring together critical functions such as disease surveillance, emergency preparedness and response, public health research, workforce development and laboratory diagnosis within a single focal point. This can lead to enhanced coordination and management of resources and enable more efficient and effective public health operations. We explored stakeholders’ perceptions about the benefits and challenges of consolidating public health functions in an NPHI in seven countries where the US Centers for Disease Control and Prevention has supported NPHI establishment and strengthening. From August 2019 through January 2020, we interviewed a total of 96 stakeholders, including NPHI staff (N = 43), non-NPHI government staff (N = 29) and non-governmental and international organization staff (N = 24) in Cambodia, Colombia, Liberia, Mozambique, Nigeria, Rwanda and Zambia. We conducted a policy analysis using Tea Collins’s health policy analysis framework to assess various possible options for coordinating public health functions and their likely effectiveness. The findings can be used by policymakers as they consider public health infrastructure. We found that consolidating functions in an NPHI, to the extent politically and organizationally feasible, promotes efficiency, flexibility and coordination, as well as supports data-driven health recommendations to government decision makers. Countries pursuing NPHI establishment can weigh the potential challenges and benefits of consolidating functions when determining which public health functions will comprise the NPHI, including clarity of role, access to resources, influence over decisions and political viability.
- 5 January 2023
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 38 (3) , 342-350
Open AccessBenefits and challenges of consolidating public health functions into a National Public Health Institute: a policy analysis
National Public Health Institutes (NPHIs) around the world vary in composition. Consolidated organizational models can bring together critical functions such as disease surveillance, emergency preparedness and response, public health research, workforce development and laboratory diagnosis within a single focal point. This can lead to enhanced coordination and management of resources and enable more efficient and effective public health operations. We explored stakeholders’ perceptions about the benefits and challenges of consolidating public health functions in an NPHI in seven countries where the US Centers for Disease Control and Prevention has supported NPHI establishment and strengthening. From August 2019 through January 2020, we interviewed a total of 96 stakeholders, including NPHI staff (N = 43), non-NPHI government staff (N = 29) and non-governmental and international organization staff (N = 24) in Cambodia, Colombia, Liberia, Mozambique, Nigeria, Rwanda and Zambia. We conducted a policy analysis using Tea Collins’s health policy analysis framework to assess various possible options for coordinating public health functions and their likely effectiveness. The findings can be used by policymakers as they consider public health infrastructure. We found that consolidating functions in an NPHI, to the extent politically and organizationally feasible, promotes efficiency, flexibility and coordination, as well as supports data-driven health recommendations to government decision makers. Countries pursuing NPHI establishment can weigh the potential challenges and benefits of consolidating functions when determining which public health functions will comprise the NPHI, including clarity of role, access to resources, influence over decisions and political viability.